Switzerland Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-10
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-switzerland
Switzerland Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-10: 10Y at 5.49%, fitted curve 3M–30Y (4.51%–5.97%), 62 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 4.51% | — |
| 6M | 4.54% | 4.67% |
| 9M | 4.57% | 4.72% |
| 2Y | 4.72% | 4.87% |
| 3Y | 4.84% | 5.16% |
| 4Y | 4.95% | 5.40% |
| 5Y | 5.06% | 5.62% |
| 6Y | 5.16% | 5.83% |
| 7Y | 5.25% | 6.03% |
| 8Y | 5.34% | 6.19% |
| 9Y | 5.42% | 6.34% |
| 10Y | 5.49% | 6.46% |
| 15Y | 5.75% | 6.67% |
| 20Y | 5.88% | 6.75% |
| 25Y | 5.94% | 6.64% |
| 30Y | 5.97% | 6.49% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.72% and the 10-year 5.49%, a 10Y−2Y spread of +77 bp — positively sloped — as of 2026-09-10. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-10 | 1m ago2026-08-11 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-13 | 5m ago2026-04-13 | 6m ago2026-03-13 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.72% | 4.48% | 4.47% | 4.40% | 4.24% | 4.14% | — |
| 10Y | 5.49% | 5.29% | 5.17% | 5.11% | 4.98% | 4.92% | 4.84% |
| 10Y − 2Y | +77 bp | +81 bp | +71 bp | +71 bp | +74 bp | +78 bp | — |
Bonds in this curve
A selection of 30 of the 63 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Roche Holding AG | 4.50% | 2026-11-13 | 5.26% | US771196CE02 |
| Roche Holding AG | 4.87% | 2027-01-28 | 2.38% | USU75000BL90 |
| Novartis | 4.34% | 2027-02-14 | 2.00% | US66989HAQ11 |
| Roche Holding AG | 4.52% | 2027-03-10 | 2.31% | USU75000BV72 |
| Novartis | 4.79% | 2027-05-17 | 3.10% | US66989HAN89 |
| Roche Holding AG | 4.78% | 2028-09-17 | 3.62% | USU75000BP05 |
| Novartis | 4.83% | 2028-11-05 | 3.90% | US66989HAX61 |
| Novartis | 4.85% | 2029-03-16 | 4.10% | US66989HBF47 |
| Novartis | 4.83% | 2029-09-18 | 3.80% | US66989HAT59 |
| Novartis | 5.11% | 2030-08-14 | 2.20% | US66989HAR93 |
| Novartis | 5.03% | 2030-11-05 | 4.10% | US66989HAY45 |
| Novartis | 5.12% | 2031-03-18 | 4.40% | US66989HBG20 |
| Novartis | 5.11% | 2031-09-18 | 4.00% | US66989HAU23 |
| Novartis | 5.25% | 2032-11-05 | 4.30% | US66989HAZ10 |
| Roche Holding AG | 5.20% | 2032-12-02 | 4.37% | USU75000CU80 |
| Novartis | 5.20% | 2033-03-18 | 4.60% | US66989HBH03 |
| Roche Holding AG | 5.29% | 2033-11-13 | 5.59% | USU75000CH79 |
| Roche Holding AG | 5.36% | 2034-09-09 | 4.59% | USU75000CQ78 |
| Novartis | 5.31% | 2034-09-18 | 4.20% | US66989HAV06 |
| Novartis | 5.38% | 2035-11-05 | 4.60% | US66989HBA59 |
| Roche Holding AG | 5.39% | 2035-12-02 | 4.67% | USU75000CV63 |
| Novartis | 5.52% | 2036-03-18 | 4.90% | US66989HBJ68 |
| Roche Holding AG | 5.62% | 2039-03-01 | 7.00% | US771196AU61 |
| Novartis | 5.77% | 2042-09-21 | 3.70% | US66989HAF55 |
| Novartis | 5.90% | 2044-05-06 | 4.40% | US66989HAH12 |
| Roche Holding AG | 5.87% | 2044-11-28 | 4.00% | USU75000BG06 |
| Novartis | 5.94% | 2050-08-14 | 2.75% | US66989HAS76 |
| Roche Holding AG | 5.92% | 2051-12-13 | 2.61% | US771196BY74 |
| Novartis | 6.02% | 2054-09-18 | 4.70% | US66989HAW88 |
| Novartis | 6.00% | 2055-11-05 | 5.30% | US66989HBC16 |